Fundraising Fox

Clarus Therapeutics Holdings

Northbrook, US · Founded 2020 · Delaware corporation

Biotech

Founders & leadership

Clarus Therapeutics Holdings was founded in 2020 by Robert E. Dudley.

RE
Robert E. DudleyFounder
JH
Joseph HernandezNamed on SEC filing
EC
Elizabeth CermakNamed on SEC filing
MA
Mark A. PrygockiNamed on SEC filing
AZ
Alex ZissonNamed on SEC filing
JK
John Kenneth AmoryNamed on SEC filing
RP
Richard PetersonNamed on SEC filing
FJ
Frank JaegerNamed on SEC filing
SB
Steven BourneNamed on SEC filing
KM
Kimberly MurphyNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$15M disclosed across 1 round · 2021

▶$15MraisedDec 2021 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Joseph HernandezDirector
  • Elizabeth CermakDirector
  • Mark A. PrygockiDirector
  • Alex ZissonDirector
  • John Kenneth AmoryDirector
  • Robert E. DudleyExecutive Officer, Director
  • Richard PetersonExecutive Officer
  • Frank JaegerExecutive Officer
  • Steven BourneExecutive Officer
  • Kimberly MurphyDirector
Offering amount
$15M
Amount sold
$15M
Sales commissions
$900K
First sale
Dec 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who founded Clarus Therapeutics Holdings?
Clarus Therapeutics Holdings was founded by Robert E. Dudley in 2020.
How much funding has Clarus Therapeutics Holdings raised?
Clarus Therapeutics Holdings has disclosed $15M raised across 1 round.
Where is Clarus Therapeutics Holdings headquartered?
Clarus Therapeutics Holdings is headquartered in Northbrook, US.